EBIT: Income before interest and taxes.
MARKER THERAPEUTICS, INC. (MRKR) had EBIT of $-2.62M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.83M |
|
-- |
|
-- |
|
$2.62M |
|
$-2.62M |
|
$0.79M |
|
$-1.83M |
|
$-1.83M |
|
$-1.83M |
|
$-1.83M |
|
$-1.83M |
|
$-1.83M |
|
|
EBIT |
$-2.62M |
$-2.62M |
|
19.31M |
|
19.31M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$14.59M |
|
-- |
|
-- |
|
$14.59M |
|
$2.42M |
|
-- |
|
-- |
|
$2.42M |
|
$12.17M |
|
$12.17M |
|
$12.17M |
|
16.70M |
|
| Cash Flow Statement Financials | |
$-5.12M |
|
-- |
|
-- |
|
$17.04M |
|
$11.92M |
|
$-5.12M |
|
$0.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.03 |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.01% |
|
-15.01% |
|
-12.52% |
|
-15.01% |
|
$0.73 |
|
$-0.27 |
|
$-0.27 |
|